Europe Pharma News

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

ipharmaservices

Jan 2

Rybrevant plus Lazcluze approved in Europe for EGFR-NSCLC; showed improvement over Tagrisso | iPharmaCenter

0

ipharmaservices

Dec 1, 2024

Novartis’ Kisqali Gains European Commission Approval for Broader Use in Early Breast Cancer Patients at High Risk of Recurrence | iPharmaCenter

0

ipharmaservices

Oct 19, 2024

EMA Drug Approvals 2024 | CHMP Positive Opinion | October 2024 | iPharmaCenter

0

ipharmaservices

Sep 3, 2024

European Commission Greenlights Keytruda and Padcev Combo as First-Line Treatment for Advanced Urothelial Carcinoma | iPharmaCenter

0

ipharmaservices

Sep 1, 2024

European Commission Expands Approval for GSK's Arexvy, the First RSV Vaccine for Adults Aged 50-59 at Increased Risk | iPharmaCenter

0

ipharmaservices

Aug 29, 2024

Roche aims PNH market with SC PiaSky, aims to target AZ's Ultomiris market | iPharmaCenter

0

ipharmaservices

Aug 27, 2024

European Union Approves Ordspono for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma | iPharmaCenter

0

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

ipharmaservices

Aug 24, 2024

Leqembi (lecanemab) Approved in Great Britain for Early-Stage Alzheimer's Disease | iPharmaCenter

0

ipharmaservices

Aug 24, 2024

The European Commission Grants Approval for Tepkinly for a New Indication in Treating Relapsed/Refractory Follicular Lymphoma in Adults | iPharmaCenter

0

ipharmaservices

Jul 4, 2024

Dupixent (Dupilumab) Gains EU Approval as the First Targeted Therapy for COPD

0

ipharmaservices

Jul 2, 2024

Committee for Medicinal Products for Human Use | CHMP Positive Opinion | June | Europe Drug Approvals | 2024 | iPharmaCenter

0

ipharmaservices

Jun 10, 2024

European Commission Approves Roche's Alecensa as First Targeted Adjuvant Therapy for Early-Stage ALK-Positive Lung Cancer | 2024 | iPharmaCenter

0

ipharmaservices

May 31, 2024

Biogen Gains European Commission Approval for QALSODY (tofersen), a Novel Therapy for a Rare Genetic Form of ALS | EMA Drug Approvals | 2024 | iPharmaCenter

0

EMA Drug Approvals | Europe drug approvals | 2024 | iPharmaCenter

ipharmaservices

Apr 23, 2024

EMA Drug Approvals | Europe drug approvals | 2024 | iPharmaCenter

0

EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenter

ipharmaservices

Mar 24, 2024

EMA Drug Approvals - CHMP Positive Opinions | March 2024 | iPharmaCenter

0

CHMP Positive Opinions | February | 2024 | iPharmaCenter

ipharmaservices

Feb 28, 2024

CHMP Positive Opinions | February | 2024 | iPharmaCenter

0

Medicines and Healthcare products Regulatory Agency | UK Drug approvals | News | iPharmaCenter

ipharmaservices

Nov 17, 2023

Medicines and Healthcare products Regulatory Agency | UK Drug approvals | News | iPharmaCenter

0

EMA Drug Approvals | CHMP Positive Opinions in October 2023 | Europe drug approvals | iPharmaCenter

ipharmaservices

Oct 17, 2023

EMA Drug Approvals | CHMP Positive Opinions in October 2023 | Europe drug approvals | iPharmaCenter

0

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

ipharmaservices

Sep 27, 2023

Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter

0

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

ipharmaservices

Jul 26, 2023

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

0

1

2 3 4

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page